Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tavoni

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Reumatismo|September 25, 2008
[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes]M Fabris, L Quartuccio, V De Re, et al.
Arthritis and Rheumatism|December 8, 2011
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitisS De Vita, L Quartuccio, M Isola, et al.
Annals of the Rheumatic Diseases|May 17, 2011
Preliminary classification criteria for the cryoglobulinaemic vasculitisS De Vita, F Soldano, M Isola, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Reumatismo|September 25, 2008
[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes]M Fabris, L Quartuccio, V De Re, et al.
Arthritis and Rheumatism|December 8, 2011
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitisS De Vita, L Quartuccio, M Isola, et al.
Annals of the Rheumatic Diseases|May 17, 2011
Preliminary classification criteria for the cryoglobulinaemic vasculitisS De Vita, F Soldano, M Isola, et al.
Pageof 7